Furthermore, there is information suggesting that BCMA/GPRC5D dual-targeted CAR-NK cells, which have demonstrated efficacy in both in vivo and in vitro models of MM [91], are derived from PB [92]. Here, TNFRSF17 is linked to Miyoshi myopathy.